{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T03:06:14Z","timestamp":1761966374517,"version":"build-2065373602"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T00:00:00Z","timestamp":1305849600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0019861","type":"journal-article","created":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T20:51:21Z","timestamp":1305924681000},"page":"e19861","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":32,"title":["A Novel Requirement for Janus Kinases as Mediators of Drug Resistance Induced by Fibroblast Growth Factor-2 in Human Cancer Cells"],"prefix":"10.1371","volume":"6","author":[{"given":"Catarina R.","family":"Carmo","sequence":"first","affiliation":[]},{"given":"Janet","family":"Lyons-Lewis","sequence":"additional","affiliation":[]},{"given":"Michael J.","family":"Seckl","sequence":"additional","affiliation":[]},{"given":"Ana P.","family":"Costa-Pereira","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2011,5,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer.","volume":"100","author":"D Hanahan","year":"2000","journal-title":"Cell"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"8658","DOI":"10.1073\/pnas.140210697","article-title":"Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs.","volume":"97","author":"S Song","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"7600","DOI":"10.1128\/MCB.23.21.7600-7610.2003","article-title":"Fibroblast growth factor 2-mediated translational control of IAPs blocks mitochondrial release of Smac\/DIABLO and apoptosis in small cell lung cancer cells.","volume":"23","author":"OE Pardo","year":"2003","journal-title":"Mol Cell Biol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1038\/sj.emboj.7601198","article-title":"FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKCepsilon, B-Raf and S6K2.","volume":"25","author":"OE Pardo","year":"2006","journal-title":"EMBO J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s004320050319","article-title":"Serum levels of vascular endothelial growth factor and basic fibroblast growth factor in patients with soft-tissue sarcoma.","volume":"125","author":"U Graeven","year":"1999","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref6","first-page":"1492","article-title":"High pretreatment serum concentration of basic fibroblast growth factor is a predictor of poor prognosis in small cell lung cancer.","volume":"11","author":"T Ruotsalainen","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1182\/blood.V94.10.3334.422k18_3334_3339","article-title":"A high pretreatment serum basic fibroblast growth factor concentration is an independent predictor of poor prognosis in non-Hodgkin's lymphoma.","volume":"94","author":"P Salven","year":"1999","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"12040","DOI":"10.1074\/jbc.M109006200","article-title":"Fibroblast growth factor-2 induces translational regulation of Bcl-XL and Bcl-2 via a MEK-dependent pathway: correlation with resistance to etoposide-induced apoptosis.","volume":"277","author":"OE Pardo","year":"2002","journal-title":"J Biol Chem"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"7658","DOI":"10.1038\/sj.onc.1204994","article-title":"Novel cross talk between MEK and S6K2 in FGF-2 induced proliferation of SCLC cells.","volume":"20","author":"OE Pardo","year":"2001","journal-title":"Oncogene"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"20059","DOI":"10.1074\/jbc.R700016200","article-title":"JAK-STAT signaling: from interferons to cytokines.","volume":"282","author":"C Schindler","year":"2007","journal-title":"J Biol Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ni.1713","article-title":"Integration of cytokine and heterologous receptor signaling pathways.","volume":"10","author":"JS Bezbradica","year":"2009","journal-title":"Nat Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc1275","article-title":"The STATs of cancer\u2013new molecular targets come of age.","volume":"4","author":"H Yu","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1600-065X.2008.00644.x","article-title":"Therapeutic targeting of Janus kinases.","volume":"223","author":"M Pesu","year":"2008","journal-title":"Immunol Rev"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1158\/0008-5472.CAN-07-6385","article-title":"Signal transducers and activators of transcription mediate fibroblast growth factor-induced vascular endothelial morphogenesis.","volume":"69","author":"X Yang","year":"2009","journal-title":"Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1242\/jcs.017160","article-title":"STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes.","volume":"121","author":"P Krejci","year":"2008","journal-title":"J Cell Sci"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1242\/jcs.02740","article-title":"Suppressors of cytokine signaling (SOCS) 1 and SOCS3 interact with and modulate fibroblast growth factor receptor signaling.","volume":"119","author":"T Ben-Zvi","year":"2006","journal-title":"J Cell Sci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1038\/sj.onc.1206479","article-title":"Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.","volume":"22","author":"L Song","year":"2003","journal-title":"Oncogene"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1073\/pnas.0710814105","article-title":"Multiple kinases in the interferon-gamma response.","volume":"105","author":"D Watling","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrm909","article-title":"Stats: transcriptional control and biological impact.","volume":"3","author":"DE Levy","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"8645","DOI":"10.1158\/0008-5472.CAN-09-1576","article-title":"The fibroblast growth factor receptor inhibitor PD173074 blocks small cell lung cancer growth in vitro and in vivo.","volume":"69","author":"OE Pardo","year":"2009","journal-title":"Cancer Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"8043","DOI":"10.1073\/pnas.122236099","article-title":"Mutational switch of an IL-6 response to an interferon-gamma-like response.","volume":"99","author":"AP Costa-Pereira","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"41679","DOI":"10.1074\/jbc.M406413200","article-title":"Alternative activation of STAT1 and STAT3 in response to interferon-gamma.","volume":"279","author":"Y Qing","year":"2004","journal-title":"J Biol Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1242\/jcs.065326","article-title":"Cross-regulation of cytokine signalling: pro-inflammatory cytokines restrict IL-6 signalling through receptor internalisation and degradation.","volume":"123","author":"S Radtke","year":"2010","journal-title":"J Cell Sci"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S1471-4906(01)02118-4","article-title":"Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling.","volume":"23","author":"CV Ramana","year":"2002","journal-title":"Trends Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-5793(03)00411-3","article-title":"Of JAKs, STATs, blind watchmakers, jeeps and trains.","volume":"546","author":"IM Kerr","year":"2003","journal-title":"FEBS Lett"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semcdb.2008.07.020","article-title":"The JAK kinases: not just another kinase drug discovery target.","volume":"19","author":"AF Wilks","year":"2008","journal-title":"Semin Cell Dev Biol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ccr.2010.10.013","article-title":"Distinct clinical phenotypes associated with JAK2V617F reflect differential STAT1 signaling.","volume":"18","author":"E Chen","year":"2010","journal-title":"Cancer Cell"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation.","volume":"454","author":"A Mantovani","year":"2008","journal-title":"Nature"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1158\/0008-5472.CAN-08-1705","article-title":"Identification of an indispensable role for tyrosine kinase 2 in CTL-mediated tumor surveillance.","volume":"69","author":"O Simma","year":"2009","journal-title":"Cancer Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1023\/A:1023805715476","article-title":"Jak family of kinases in cancer.","volume":"22","author":"A Verma","year":"2003","journal-title":"Cancer Metastasis Rev"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1101\/gad.12.16.2475","article-title":"Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies.","volume":"12","author":"G Packham","year":"1998","journal-title":"Genes Dev"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"12350","DOI":"10.1074\/jbc.272.19.12350","article-title":"The kinase domain of Jak2 mediates induction of bcl-2 and delays cell death in hematopoietic cells.","volume":"272","author":"I Sakai","year":"1997","journal-title":"J Biol Chem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/ni910","article-title":"Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock.","volume":"4","author":"M Karaghiosoff","year":"2003","journal-title":"Nat Immunol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/emboj\/cdg038","article-title":"The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.","volume":"22","author":"J Ragimbeau","year":"2003","journal-title":"EMBO J"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1073\/pnas.90.8.3516","article-title":"MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2.","volume":"90","author":"KM Kozopas","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nature08822","article-title":"The landscape of somatic copy-number alteration across human cancers.","volume":"463","author":"R Beroukhim","year":"2010","journal-title":"Nature"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0019861","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T11:03:58Z","timestamp":1592564638000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0019861"}},"subtitle":[],"editor":[{"given":"Rakesh K.","family":"Srivastava","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2011,5,20]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2011,5,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0019861","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2011,5,20]]}}}